3D-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs

References

• Avti PK, Caparelli ED, Sitharaman B. (2013). Cytotoxicity, cytocompatibility, cell-labeling efficiency, and in vitro cellular magnetic resonance imaging of gadolinium-catalyzed single-walled carbon nanotubes. J Biomed Mater Res A 101:3580–91.
   PubMed Web of Science ®Google Scholar
• Awad A, Fina F, Goyanes A, et al. (2020). 3D printing: principles and pharmaceutical applications of selective laser sintering. Int J Pharm 586:119594.
   PubMed Web of Science ®Google Scholar
• Ayala AP, Siesler HW, Boese R, et al. (2006). Solid state characterization of olanzapine polymorphs using vibrational spectroscopy. Int J Pharm 326:69–79.
   PubMed Web of Science ®Google Scholar
• Barrett SE, Teller RS, Forster SP, et al. (2018). Extended-duration MK-8591-eluting implant as a candidate for HIV treatment and prevention. Antimicrob Agents Chemother 62:e01058-18.
   PubMed Web of Science ®Google Scholar
• Borandeh S, van Bochove B, Teotia A, Seppälä J. (2021). Polymeric drug delivery systems by additive manufacturing. Adv Drug Deliv Rev 173:349–73.
   PubMed Web of Science ®Google Scholar
• Burugapalli K, Razavi M, Zhou L, Huang Y. (2016). In vitro cytocompatibility study of a medical β-type Ti–35.5Nb–5.7Ta titanium alloy. J Biomater Tissue Eng 6:141–8.
   Web of Science ®Google Scholar
• Chen Q, Mangadlao JD, Wallat J, et al. (2017). 3D printing biocompatible polyurethane/poly(lactic acid)/graphene oxide nanocomposites: anisotropic properties. ACS Appl Mater Interfaces 9:4015–23.
   PubMed Web of Science ®Google Scholar
• Cho H-W, Baek S-H, Lee B-J, Jin H-E. (2020). Orodispersible polymer films with the poorly water-soluble drug, olanzapine: hot-melt pneumatic extrusion for single-process 3D printing. Int Pharm 12:692.
   PubMed Web of Science ®Google Scholar
• Chua CYX, Jain P, Ballerini A, et al. (2018). Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. J Control Release 286:315–25.
   PubMed Web of Science ®Google Scholar
• Dash A, Cudworth G. (1998). Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 40:1–12.
   PubMed Web of Science ®Google Scholar
• de Almeida HRO, de Carvalho Patricio BF, do Anjos Garcia Y, et al. (2021). Production of biodegradable rods of polycaprolactone/olanzapine for potential application in treatment of schizophrenia. J Appl Polym Sci 138:50944.
   Web of Science ®Google Scholar
• Delivery T. (2012). Micro- and nano-fabricated implantable drug-delivery systems. Ther Deliv 3:1457–67.
   PubMedGoogle Scholar
• Delpor. (2022). Available at: https://delpor.com/delpors-device/ [last accessed 8 Mar 2022].
   Google Scholar
• Delpor. (2020). Safety, tolerability, and pharmacokinetics of switching from oral risperidone to risperidone implant (DLP-114). Available at: https://clinicaltrials.gov/ct2/show/record/NCT04418466
   Google Scholar
• Domínguez-Robles J, Diaz-Gomez L, Utomo E, et al. (2021). Use of 3D printing for the development of biodegradable antiplatelet materials for cardiovascular applications. Pharmaceuticals 14:921.
   Web of Science ®Google Scholar
• Domínguez-Robles J, Mancinelli C, Mancuso E, et al. (2020). 3D printing of drug-loaded thermoplastic polyurethane meshes: a potential material for soft tissue reinforcement in vaginal surgery. Pharmaceutics 12:63.
   PubMed Web of Science ®Google Scholar
• Domsta V, Seidlitz A. (2021). 3D-printing of drug-eluting implants: an overview of the current developments described in the literature. Molecules 26:4066.
   PubMed Web of Science ®Google Scholar
• Dunican KC, DelDotto D. (2007). The role of olanzapine in the treatment of anorexia nervosa. Ann Pharmacother 41:111–5.
   PubMed Web of Science ®Google Scholar
• Elamparithi A, Punnoose AM, Kuruvilla S, et al. (2016). Electrospun polycaprolactone matrices with tensile properties suitable for soft tissue engineering. Artif Cells Nanomed Biotechnol 44:878–84.
   PubMed Web of Science ®Google Scholar
• FDA. (2017). Q3C—tables and list guidance for industry. Microsoft Word 9765:1–8.
   Google Scholar
• Gendelman HE, McMillan JE, Bade AN, et al. (2019). The promise of long-acting antiretroviral therapies: from need to manufacture. Trends Microbiol 27:593–606.
   PubMed Web of Science ®Google Scholar
• Govender T, Choonara YE, Kumar P, et al. (2017). Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol 22:476–86.
   PubMed Web of Science ®Google Scholar
• Gref R, Domb A, Quellec P, et al. (1995). The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16:215–33.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. (2001). Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: a case report. J Cutan Med Surg 5:25–7.
   PubMed Web of Science ®Google Scholar
• Ho SC, Chong HY, Chaiyakunapruk N, et al. (2016). Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord 193:1–10.
   PubMed Web of Science ®Google Scholar
• Hong J, Reed C, Novick D, et al. (2011). Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study. Psychiatry Res 190:110–4.
   PubMed Web of Science ®Google Scholar
• Karunakaran D, Simpson SM, Su JT, et al. (2021). Design and testing of a cabotegravir implant for HIV prevention. J Control Release 330:658–68.
   PubMed Web of Science ®Google Scholar
• Khaled SA, Alexander MR, Irvine DJ, et al. (2018). Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry. AAPS PharmSciTech 19:3403–13.
   PubMed Web of Science ®Google Scholar
• Khaled SA, Alexander MR, Wildman RD, et al. (2018). 3D extrusion printing of high drug loading immediate release paracetamol tablets. Int J Pharm 538:223–30.
   PubMed Web of Science ®Google Scholar
• Khaled SA, Burley JC, Alexander MR, Roberts CJ. (2014). Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm 461:105–11.
   PubMed Web of Science ®Google Scholar
• Khaled SA, Burley JC, Alexander MR, et al. (2015). 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release 217:308–14.
   PubMed Web of Science ®Google Scholar
• Laing B, De Keyzer J, Seveno D, Van Bael A. (2020). Effect of co-agents on adhesion between peroxide cured ethylene–propylene–diene monomer and thermoplastics in two-component injection molding. J Appl Polym Sci 137:48414.
   Web of Science ®Google Scholar
• Lam CXF, Hutmacher DW, Schantz JT, et al. (2009). Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A 90:906–19.
   PubMed Web of Science ®Google Scholar
• Langer R. (1990). New methods of drug delivery. Science 249:1527–33.
   PubMed Web of Science ®Google Scholar
• Leggero C, Masi G, Brunori E, et al. (2010). Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity. J Child Adolesc Psychopharmacol 20:127–33.
   PubMed Web of Science ®Google Scholar
• Li L, Gatto GJ, Brand RM, et al. (2021). Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones. J Control Release 340:188–99.
   PubMed Web of Science ®Google Scholar
• Li L, Johnson LM, Krovi SA, et al. (2020). Performance and stability of tenofovir alafenamide formulations within subcutaneous biodegradable implants for HIV pre-exposure prophylaxis (PrEP). Pharmaceutics 12:1057.
   PubMed Web of Science ®Google Scholar
• Lin D, Thompson-Leduc P, Ghelerter I, et al. (2021). Real-world evidence of the clinical and economic impact of long-acting injectable versus oral antipsychotics among patients with schizophrenia in the United States: a systematic review and meta-analysis. CNS Drugs 35:469–81.
   PubMed Web of Science ®Google Scholar
• Lindenmayer J-P. (2010). Long-acting injectable antipsychotics: focus on olanzapine pamoate. Neuropsychiatr Dis Treat 6:261–7.
   PubMed Web of Science ®Google Scholar
• Luo H, Hao X, Gong Y, et al. (2019). Rational crystal polymorph design of olanzapine. Cryst Growth Des 19:2388–95.
   Web of Science ®Google Scholar
• Martin NK, Domínguez-Robles J, Stewart SA, et al. (2021). Fused deposition modelling for the development of drug loaded cardiovascular prosthesis. Int J Pharm 595:120243.
   PubMed Web of Science ®Google Scholar
• Mathew E, Domínguez-Robles J, Stewart SA, et al. (2019). Fused deposition modeling as an effective tool for anti-infective dialysis catheter fabrication. ACS Biomater Sci Eng 5:6300–10.
   PubMed Web of Science ®Google Scholar
• Melocchi A, Uboldi M, Cerea M, et al. (2020). A graphical review on the escalation of fused deposition modeling (FDM) 3D printing in the pharmaceutical field. J Pharm Sci 109:2943–57.
   PubMed Web of Science ®Google Scholar
• National Health Service (NHS). (2021). Olanzapine. 27 July. https://www.nhs.uk/medicines/olanzapine/.
   Google Scholar
• Okamoto H, Shono K, Nozaki-Taguchi N. (2019). Low-dose of olanzapine has ameliorating effects on cancer-related anorexia. Cancer Manag Res 11:2233–9.
   PubMed Web of Science ®Google Scholar
• Paredes AJ, Camacho NM, Schofs L, et al. (2020). Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug. Int J Pharm 585:119501.
   PubMed Web of Science ®Google Scholar
• Paredes AJ, Volpe-Zanutto F, Permana AD, et al. (2021). Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride. Int J Pharm 606:120885.
   PubMed Web of Science ®Google Scholar
• Parellada E, Bioque M. (2016). Barriers to the use of long-acting injectable antipsychotics in the management of schizophrenia. CNS Drugs 30:689–701.
   PubMed Web of Science ®Google Scholar
• Pons-Faudoa FP, Ballerini A, Sakamoto J, Grattoni A. (2019). Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases. Biomed Microdev 21:47.
   PubMed Web of Science ®Google Scholar
• Rabin C, Liang Y, Ehrlichman RS, et al. (2008). In vitro and in vivo demonstration of risperidone implants in mice. Schizophr Res 98:66–78.
   PubMed Web of Science ®Google Scholar
• Rajgor N, Bhaskar V, Patel M. (2011). Implantable drug delivery systems: an overview. Syst Rev Pharm 2:91.
   Google Scholar
• Rydholm AE, Anseth KS, Bowman CN. (2007). Effects of neighboring sulfides and pH on ester hydrolysis in thiol-acrylate photopolymers. Acta Biomater 3:449–55.
   PubMed Web of Science ®Google Scholar
• Sailema-Palate GP, Vidaurre A, Campillo-Fernández AJ, Castilla-Cortázar I. (2016). A comparative study on poly(ε-caprolactone) film degradation at extreme pH values. Polym Degrad Stab 130:118–25.
   Web of Science ®Google Scholar
• Schlesinger E, Johengen D, Luecke E, et al. (2016). A tunable, biodegradable, thin-film polymer device as a long-acting implant delivering tenofovir alafenamide fumarate for HIV pre-exposure prophylaxis. Pharm Res 33:1649–56.
   PubMed Web of Science ®Google Scholar
• Serrano MC, Pagani R, Vallet-Regı́ M, et al. (2004). In vitro biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials 25:5603–11.
   PubMed Web of Science ®Google Scholar
• Sim LH, Gan SN, Chan CH, Yahya R. (2010). ATR-FTIR studies on ion interaction of lithium perchlorate in polyacrylate/poly(ethylene oxide) blends. Spectrochim Acta A Mol Biomol Spectrosc 76:287–92.
   PubMed Web of Science ®Google Scholar
• Sohi H, Sultana Y, Khar RK. (2004). Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 30:429–48.
   PubMed Web of Science ®Google Scholar
• Stewart AS, Domínguez-Robles J, Donnelly RF, et al. (2018). Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers 10:1379.
   PubMed Web of Science ®Google Scholar
• Stewart SA, Domínguez-Robles J, McIlorum VJ, et al. (2020). Poly(caprolactone)-based coatings on 3D-printed biodegradable implants: a novel strategy to prolong delivery of hydrophilic drugs. Mol Pharm 17:3487–500.
   PubMed Web of Science ®Google Scholar
• Stewart SA, Domínguez-Robles J, Utomo E, et al. (2021). Poly(caprolactone)-based subcutaneous implant for sustained delivery of levothyroxine. Int J Pharm 607:121011.
   PubMed Web of Science ®Google Scholar
• Stewart S, Domínguez-Robles J, McIlorum V, et al. (2020). Development of a biodegradable subcutaneous implant for prolonged drug delivery using 3D printing. Pharmaceutics 12:105.
   PubMed Web of Science ®Google Scholar
• Testa CG, Prado LD, Costa RN, et al. (2019). Challenging identification of polymorphic mixture: polymorphs I, II and III in olanzapine raw materials. Int J Pharm 556:125–35.
   PubMed Web of Science ®Google Scholar
• Van Boven JFM, Chavannes NH, Van Der Molen T, et al. (2014). Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med 108:103–13.
   PubMed Web of Science ®Google Scholar
• Volpe-Zanutto F, Ferreira LT, Permana AD, et al. (2021). Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii. J Control Release 333:298–315.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun L, Mei Z, et al. (2020). 3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma. Mater Des 186:108336.
   Web of Science ®Google Scholar
• Wang Z, Yang Y. (2021). Application of 3D printing in implantable medical devices. Biomed Res Int 2021:6653967.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang C, Zhang Z, et al. (2022). Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma. Drug Deliv 29:613–23.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hernandez C, Goss M, et al. (2015). Biomedical imaging in implantable drug delivery systems. Curr Drug Targets 16:672–82.
   PubMed Web of Science ®Google Scholar